Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy

Overview

Journal Cell J

Specialty Cell Biology

Date 2017 Apr 4

PMID 28367411

Citations 268

Authors

Nazem Ghasemi

Shahnaz Razavi

Elham Nikzad

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) lesions that can lead to severe physical or cognitive disability as well as neurological defects. Although the etiology and pathogenesis of MS remains unclear, the present documents illustrate that the cause of MS is multifactorial and include genetic predisposition together with environmental factors such as exposure to infectious agents, vitamin deficiencies, and smoking. These agents are able to trigger a cascade of events in the immune system which lead to neuronal cell death accompanied by nerve demyelination and neuronal dysfunction. Conventional therapies for MS are based on the use of anti-inflammatory and immunomodulatory drugs, but these treatments are not able to stop the destruction of nerve tissue. Thus, other strategies such as stem cell transplantation have been proposed for the treatment of MS. Overall, it is important that neurologists be aware of current information regarding the pathogenesis, etiology, diagnostic criteria, and treatment of MS. Thus, this issue has been discussed according to recent available information.

Citing Articles

Thyroid function and multiple sclerosis: a two-sample mendelian randomization study and mediation analysis.

Ren Y, Wang X, Wang W, Wang Z Sci Rep. 2025; 15(1):9022.

PMID: 40089493 DOI: 10.1038/s41598-025-89888-z.

The Relationship Between Multiple Sclerosis and Obesity: A Comparative Study.

Salih S, Hashim A, Hasrat N, Farid H Cureus. 2025; 17(2):e78530.

PMID: 40062043 PMC: 11885895. DOI: 10.7759/cureus.78530.

Nondiabetic Gastroparesis Among Multiple Sclerosis Patients: A Retrospective Analysis of Patient Characteristics From the United States.

Verma R, Ramphul K, Liu L, Sakthivel H, Pekyi-Boateng P, Pekyi-Boateng P Health Sci Rep. 2025; 8(3):e70538.

PMID: 40051491 PMC: 11882475. DOI: 10.1002/hsr2.70538.

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity.

de Rezende V, de Aguiar da Costa M, Martins C, Mathias K, Goncalves C, Barichello T Neurochem Res. 2025; 50(2):112.

PMID: 40035979 DOI: 10.1007/s11064-025-04361-7.

Myelin-reactive CD8 T cells influence conventional dendritic cell subsets towards a mature and regulatory phenotype in experimental autoimmune encephalomyelitis.

Upadhye M, Wilhelm C, Rogers K, Vemulawada C, Borcherding N, Boyden A J Neuroinflammation. 2025; 22(1):54.

PMID: 40022134 PMC: 11869544. DOI: 10.1186/s12974-025-03377-8.

References

Kasper L, Shoemaker J . Multiple sclerosis immunology: The healthy immune system vs the MS immune system. Neurology. 2009; 74 Suppl 1:S2-8. DOI: 10.1212/WNL.0b013e3181c97c8f. View

Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove C, Bovenkerk J . Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004; 109(10):1292-8. DOI: 10.1161/01.CIR.0000121425.42966.F1. View

La Mantia L, Milanese C, Mascoli N, DAmico R, Weinstock-Guttman B . Cyclophosphamide for multiple sclerosis. Cochrane Database Syst Rev. 2007; (1):CD002819. PMC: 8078225. DOI: 10.1002/14651858.CD002819.pub2. View

Baarnhielm M, Hedstrom A, Kockum I, Sundqvist E, Gustafsson S, Hillert J . Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol. 2012; 19(7):955-62. DOI: 10.1111/j.1468-1331.2011.03650.x. View

Mohyeddin Bonab M, Mohajeri M, Sahraian M, Yazdanifar M, Aghsaie A, Farazmand A . Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells. Arch Med Res. 2013; 44(4):266-72. DOI: 10.1016/j.arcmed.2013.03.007. View

Sadovnick A, Ebers G, Dyment D, Risch N . Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet. 1996; 347(9017):1728-30. DOI: 10.1016/s0140-6736(96)90807-7. View

Gadoth N . Multiple sclerosis in children. Brain Dev. 2003; 25(4):229-32. DOI: 10.1016/s0387-7604(03)00035-4. View

Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F . Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Tissue Antigens. 2003; 61(2):166-71. DOI: 10.1046/j.0001-2815.2002.00008.x. View

Compston A, Coles A . Multiple sclerosis. Lancet. 2008; 372(9648):1502-17. DOI: 10.1016/S0140-6736(08)61620-7. View

10.

Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E . Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells. 2009; 27(10):2624-35. DOI: 10.1002/stem.194. View

11.

Ciccone A, Beretta S, Brusaferri F, Galea I, Protti A, Spreafico C . Corticosteroids for the long-term treatment in multiple sclerosis. Cochrane Database Syst Rev. 2008; (1):CD006264. DOI: 10.1002/14651858.CD006264.pub2. View

12.

Thom S, Bhopale V, Fisher D, Zhang J, Gimotty P . Delayed neuropathology after carbon monoxide poisoning is immune-mediated. Proc Natl Acad Sci U S A. 2004; 101(37):13660-5. PMC: 518809. DOI: 10.1073/pnas.0405642101. View

13.

Dawson V, Dawson T, Bartley D, Uhl G, Snyder S . Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993; 13(6):2651-61. PMC: 6576487. View

14.

Trubiani O, Giacoppo S, Ballerini P, Diomede F, Piattelli A, Bramanti P . Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis. Stem Cell Res Ther. 2016; 7:1. PMC: 4700621. DOI: 10.1186/s13287-015-0253-4. View

15.

Azimi Alamouti M, Bakhtiyari M, Moradi F, Mokhtari T, Hedayatpour A, Zafari F . Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis. Acta Med Iran. 2015; 53(9):533-9. View

16.

Fujinami R, von Herrath M, Christen U, Whitton J . Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006; 19(1):80-94. PMC: 1360274. DOI: 10.1128/CMR.19.1.80-94.2006. View

17.

Stewart G, McLeod J, Basten A, Bashir H . HLA family studies and multiple sclerosis: A common gene, dominantly expressed. Hum Immunol. 1981; 3(1):13-29. DOI: 10.1016/0198-8859(81)90040-9. View

18.

Speer G . [Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis]. Ideggyogy Sz. 2013; 66(9-10):293-303. View

19.

Kouchaki E, Salehi M, Sharif M, Nikoueinejad H, Akbari H . Numerical status of CD4(+)CD25(+)FoxP3(+) and CD8(+)CD28(-) regulatory T cells in multiple sclerosis. Iran J Basic Med Sci. 2014; 17(4):250-5. PMC: 4046232. View

20.

Gandhi R, Laroni A, Weiner H . Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2009; 221(1-2):7-14. PMC: 2854189. DOI: 10.1016/j.jneuroim.2009.10.015. View